Medical Equipment

IonOpticks enters OEM partnership with Bruker that sets a new standard for mass spectrometry-based research

MELBOURNE, Australia, Feb. 7, 2022 /PRNewswire/ -- Premium manufacturer of chromatography for proteomics applications, IonOpticks, has entered an OEM partnership with the Bruker Corporation (Nasdaq: BRKR), allowing Bruker to expand their portfolio of 4D-Proteomics solutions with the release of th...

2022-02-08 00:01 2577

Covaris AFA-energetics™ Enables True Automated Total Nucleic Acid Extraction and Purification Workflows from FFPE Tissues

A fully automated, high-throughput deparaffinization and total Nucleic Acids extraction and purification kit for FFPE samples WOBURN, Mass., Feb. 7, 2022 /PRNewswire/ -- Covaris, LLC ("Covaris" or "the Company"), a manufacturer of advanced tools enabling life science innovations, announced the l...

2022-02-07 23:00 3711

Clarivate Identifies Seven Medtech Trends to Watch in 2022

LONDON, Feb. 7, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new report,Outlook on the Medtech Industry: Seven Areas to Watch. The report analyzes seven factors that Clarivate ...

2022-02-07 16:00 2561

Genesis MedTech Acquires JC Medical, Creates New Structural Heart Franchise

SINGAPORE, Feb. 4, 2022 /PRNewswire/ -- Genesis MedTech Group (Genesis or Group) has completed the acquisition of JC Medical (JCM), a  structural heart company that is primarily engaged in the design and development of transcatheter valve replacement products for the minimally invasive treatment ...

2022-02-05 08:00 5014

Vitro S.A. sells Cytognos to BD to prioritize the market launch of their new and disruptive Molecular Biology and Anatomic Pathology diagnostic platforms

Cytognos divestment is a first strategic step aimed at positioning Vitro as a new worldwide diagnostic player in their key market segments SEVILLE, Spain, Feb. 4, 2022 /PRNewswire/ -- Vitro S.A, (www.vitro.bio ) a privately held company headquartered in Seville, Spain, ann...

2022-02-04 17:23 4980

Invitation to the presentation of Elekta's third quarter 2021/22

STOCKHOLM, Feb. 4, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the third quarter 2021/22 at10:00 a.m. CET on February 24. The interim report for the third quarter will be published at 7:30 a.m. CET on the same day. The company's development will be...

2022-02-04 15:57 4128

Mentice publishes the company's year-end report for the period January-December 2021

STOCKHOLM, Feb. 3, 2022 /PRNewswire/ -- Continued strength with net sales growth above 30% despite the pandemic Fourth quarter (October-December 2021) * Order intake amounted to 73.7 (73.1) MSEK. * Net sales amounted to 67.7 (45.9) MSEK. * Operating income for the period before depreciation...

2022-02-03 15:37 2496

Formus Labs Raises $5 Million to Automate Orthopedic Surgery Planning; Partners With Zimmer Biomet to Supercharge Global Launch

Formus combines AI and biomechanics to empower orthopedic surgeons with fully interactive 3D models to optimize the preoperative planning process AUCKLAND, New Zealand, Feb. 3, 2022 /PRNewswire/ -- Formus Labs, the world's first automated 3D planner for joint replacement surgeries, today announce...

2022-02-03 03:00 3470

Zeus Launches PTFE Sub-Lite-Wall® Multi-Lumen Tubing for Steerable Catheters

New Multi-Lumen Tubing Helps Simplify Steerable Catheter Construction, Reduce Manufacturing Steps, and Improve Yields ORANGEBURG, S.C., Feb. 2, 2022 /PRNewswire/ -- Zeus, the global leader in advanced polymer solutions, announced today that it has added PTFE Sub-Lite-Wall ® multi-lumen tubing to ...

2022-02-02 21:00 2499

Elekta increases customer focus with direct presence in Philippines

STOCKHOLM, Feb. 2, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has established an office inthe Philippines' capital, Manila, to offer new and existing customers superior service, education and training opportunities and faster access to the latest cancer care solutions. A dire...

2022-02-02 15:48 3141

LANDMARK REDUCE LAP-HF II TRIAL DEMONSTRATES CLINICAL BENEFIT OF CORVIA® ATRIAL SHUNT IN LARGE SEGMENT OF HEART FAILURE PATIENTS

REDUCE LAP-HF II study defines treatable HFpEF patient population for atrial shunt therapy TEWKSBURY, Mass., Feb. 2, 2022 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), today announced results from its REDUCE LAP-HF II randomized cli...

2022-02-02 01:28 2489

LANDMARK REDUCE LAP-HF II TRIAL DEMONSTRATES CLINICAL BENEFIT OF CORVIA® ATRIAL SHUNT IN LARGE SEGMENT OF HEART FAILURE PATIENTS

REDUCE LAP-HF II study defines treatable HFpEF patient population for atrial shunt therapy TEWKSBURY, Mass., Feb. 1, 2022 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), today announced results from its REDUCE LAP-HF II randomized cli...

2022-02-01 22:50 2575

DEBIOPHARM AND ASPEN PARTNER TO LAUNCH PROSTATE CANCER DRUG TRELSTAR® IN SOUTH AFRICA

LAUSANNE, Switzerland and DURBAN, South Africa, Feb. 1, 2022 /PRNewswire/ -- Debiopharm (www.debiopharm.com ), a Swiss biopharmaceutical company andAspen, a South African headquartered multinational pharmaceutical company announced today their partnership to  launch Tr...

2022-02-01 06:00 3690

Pfizer and Alex Therapeutics announce a Strategic Commercial Partnership to provide evidence-based Digital Therapeutics to patients, starting in Germany

STOCKHOLM, Jan. 31, 2022 /PRNewswire/ -- The Stockholm-based Digital Therapeutics (DTx) company Alex Therapeutics and world leading pharmaceutical company Pfizer have joined forces to provide evidence based, clinically validated and personalized digital therapies to patients. Together, the compa...

2022-01-31 18:00 2672

Much Awaited, Much Needed: TRANSFORM II Randomized Controlled Trial, by Fondazione RIC, gets rolling

MILANO, Italy, Jan. 28, 2022 /PRNewswire/ -- FONDAZIONE Ricerca e Innovazione Cardiovascolare,Milano, focused on cardiovascular research, reports the first patient enrolment of theTRANSFORM II Randomized Controlled Trial (Sirolimus-coa...

2022-01-28 20:34 5038

Ready to Enter the Middle East Market, Vazyme Showcases Its COVID-19 Testing Solutions at Medlab Middle East 2022

DUBAI, UAE, Jan. 28, 2022 /PRNewswire/ -- Leading China-based biotech company Vazyme (688105.SH) participated in the 2022 edition of Medlab Middle East in the Dubai World Trade Centre (DWTC) fromJanuary 24th to 27th, a leading laboratory and flagship exhibition and conference that brings together...

2022-01-28 13:00 5307

Enable Injections Announces $215 Million Financing

New financing provides significant financial flexibility to propel growth efforts, benefitting patients, providers, and pharma partners worldwide. CINCINNATI, Jan. 27, 2022 /PRNewswire/ -- Enable Injections, Inc. ("Enable"), a company developing and manufacturing the enFuse® platform of investiga...

2022-01-27 23:35 5100

Mentice's CEO Goran Malmberg to present the company's Year-end Report Q4 2021 at a webcast conference call on February 3rd at 9:30 CET

STOCKHOLM, Jan. 27, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its year-end report via a webcast conference call with the opportunity for interested parties to ask questions to CEOGoran Malmberg and CFOGunilla Andersson. To register for the presentation o...

2022-01-27 17:42 2243

iMediSync Successfully Launches the Future of Tele-Medicare at CES 2022

SEOUL, South Korea, Jan. 27, 2022 /PRNewswire/ -- iMediSync, A biotech startup company fromSeoul, South Korea, successfully debuted at CES 2022 to introduce the new trend of digital healthcare under their motto – Overcome Mental Pandemic in just 10 Min.

2022-01-27 08:00 5300

iMediSync Successfully Launches the Future of Tele-Medicare at CES 2022

SEOUL, South Korea, Jan. 26, 2022 /PRNewswire/ -- iMediSync, A biotech startup company fromSeoul, South Korea, successfully debuted at CES 2022 to introduce the new trend of digital healthcare under their motto – Overcome Mental Pandemic in just 10 Min.

2022-01-26 22:00 4281
1 ... 118119120121122123124 ... 145